Financhill
Back

Alimera Sciences Quote, Financials, Valuation and Earnings

Alimera Sciences Price Quote

$5.53
+0.01 (+0.18%)
(Updated: July 4, 2024 at 5:38 AM ET)

Alimera Sciences Key Stats

Buy
91
Alimera Sciences (ALIM) is a Buy

Day range:
$5.52 - $5.54
52-week range:
$2.60 - $5.65
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.25
P/B ratio:
7.11%

Volume:
267.7K
Avg. volume:
587.6K
1-year change:
88.4%
Market cap:
$289.2M
Revenue:
$80.8M
EPS:
$-1.57

How Much Does Alimera Sciences Make?

Is Alimera Sciences Growing As A Company?

  • What Is Alimera Sciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.7%
  • What Is Alimera Sciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Alimera Sciences Stock Price Performance

  • Did Alimera Sciences Stock Go Up Last Month?
    Alimera Sciences share price went up by 80.98% last month
  • Did ALIM's Share Price Rise Over The Last Year?
    ALIM share price rose by 88.4% over the past 1 year

What Is Alimera Sciences 52-Week High & Low?

Alimera Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Alimera Sciences?

  • How Much Debt Does Alimera Sciences Have?
    Total long term debt quarterly is $69.4M
  • How Much Cash Does Alimera Sciences Have?
    Cash and short term investments quarterly total is $14.3M
  • What Is Alimera Sciences’s Book Value Per Share?
    Book value per share is 0.78

Is Alimera Sciences Cash Flow Positive?

  • What Is ALIM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$12.6M
  • What Is Alimera Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $89.5M
  • What Is Alimera Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$75.5M

Alimera Sciences Return On Invested Capital

  • Is Management Doing A Good Job?
    ALIM return on invested capital is -22.82%
  • What Is Alimera Sciences Return On Assets?
    ROA measures how assets are converting to revenues and is -16.14%
  • What Is ALIM Return On Equity?
    ROE is a measure of profitability and is -65.7%

Alimera Sciences Earnings Date & Stock Price

Alimera Sciences Competitors

  • Who Are Alimera Sciences's Competitors?
    Below is a list of companies who compete with Alimera Sciences or are related in some way:
    • Alnylam Pharmaceuticals Inc (ALNY)
    • ANI Pharmaceuticals Inc (ANIP)
    • G1 Therapeutics Inc (GTHX)
    • Reneo Pharmaceuticals Inc (RPHM)
    • Sarepta Therapeutics Inc (SRPT)

Alimera Sciences Dividend Yield

Data Unavailable

Alimera Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -257.67%
Revenue: 69.87% 3.42%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 5.67
Upside from Last Price: 2.66%

Major Shareholders

  • How many ALIM shares are owned by institutional investors?
    50.6M ALIM shares are owned by institutional investors
  • How many ALIM shares are owned by insiders?
    1.6M ALIM shares are owned by insiders